A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma
一项评估小剂量硼替佐米、来那度胺和地塞米松(sVRD)作为多发性骨髓瘤患者巩固/维持治疗的II期临床试验
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-016-3163-y
Ibata, Soushi; Sato, Tsutomu; Kuroda, Hiroyuki; Nagamachi, Yasuhiro; Iyama, Satoshi; Fujimi, Akihito; Kamihara, Yusuke; Konuma, Yuichi; Yoshida, Masahiro; Tatekoshi, Ayumi; Hashimoto, Akari; Horiguchi, Hiroto; Ono, Kaoru; Murase, Kazuyuki; Takada, Kohichi; Miyanishi, Koji; Kobune, Masayoshi; Hirayama, Yasuo; Kato, Junji